The relationship between the apolipoprotein E e4 allele and hippocampal magnetic resonance imaging volume in community-dwelling individuals with mild Alzheimer's disease
Author(s): Walsh B | Slater S | Nair B | Attia J
Volume: 2013
Issue: default
Year: 2013
Author(s): Walsh B | Slater S | Nair B | Attia J Volume: 2013 Issue: default Year: 2013
An update on the management of young-onset Parkinson's disease
Author(s): Klepac N | Habek M | Adamec I | Barušić AK | Bach I | Margetić E | Lušić I
Volume: 2013
Issue: default
Year: 2013
Author(s): Klepac N | Habek M | Adamec I | Barušić AK | Bach I | Margetić E | Lušić I Volume: 2013 Issue: default Year: 2013
The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegeneration
Author(s): King RR | Reiss JP
Volume: 2013
Issue: default
Year: 2013
Author(s): King RR | Reiss JP Volume: 2013 Issue: default Year: 2013
Knowledge among physical education professionals about poliomyelitis and post-poliomyelitis syndrome: a cross-sectional study in Brazil
Author(s): de Lira CA | Almeida Alves TM | Peixinho-Pena LF | Sousa BS | Santana MG | Benite-Ribeiro SA | Andrade MS | Vancini RL
Volume: 2013
Issue: default
Year: 2013
Author(s): de Lira CA | Almeida Alves TM | Peixinho-Pena LF | Sousa BS | Santana MG | Benite-Ribeiro SA | Andrade MS | Vancini RL Volume: 2013 Issue: default Year: 2013
Behavioral assessment of visual deficits in the taiep mutant
Author(s): Bloom CM | Post RJ | Anch AM | Davenport DG
Volume: 2013
Issue: default
Year: 2013
Author(s): Bloom CM | Post RJ | Anch AM | Davenport DG Volume: 2013 Issue: default Year: 2013
The pharmacologic management of depression in Parkinson's disease
Author(s): Schreiber MA | Thompson AW
Volume: 2013
Issue: default
Year: 2013
Author(s): Schreiber MA | Thompson AW Volume: 2013 Issue: default Year: 2013
Clinical utility of DaTscan™ (123I-Ioflupane Injection) in the diagnosis of Parkinsonian Syndromes
Author(s): Roussakis AA | Piccini P | Politis M
Volume: 2013
Issue: default
Year: 2013
Author(s): Roussakis AA | Piccini P | Politis M Volume: 2013 Issue: default Year: 2013
Inclusion body myositis: therapeutic approaches
Author(s): Aggarwal R | Oddis CV
Volume: 2012
Issue: default
Year: 2012
Author(s): Aggarwal R | Oddis CV Volume: 2012 Issue: default Year: 2012
New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience
Author(s): Suhr OB | Gustavsson S | Heldestad V | Hörnsten R | Lindqvist P | Nordh E | Wiklund U
Volume: 2012
Issue: default
Year: 2012
Author(s): Suhr OB | Gustavsson S | Heldestad V | Hörnsten R | Lindqvist P | Nordh E | Wiklund U Volume: 2012 Issue: default Year: 2012
Cell adhesion molecules in Alzheimer's disease
Author(s): Wennström M | Nielsen HM
Volume: 2012
Issue: default
Year: 2012
Author(s): Wennström M | Nielsen HM Volume: 2012 Issue: default Year: 2012
Recent advances in Duchenne muscular dystrophy
Author(s): Perkins KJ | Davies KE
Volume: 2012
Issue: default
Year: 2012
Author(s): Perkins KJ | Davies KE Volume: 2012 Issue: default Year: 2012
Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic disease
Author(s): Levin MC | Lee S | Gardner LA | Shin Y | Douglas JN | Groover CJ
Volume: 2012
Issue: default
Year: 2012
Author(s): Levin MC | Lee S | Gardner LA | Shin Y | Douglas JN | Groover CJ Volume: 2012 Issue: default Year: 2012
BG-12 and its potential for the prevention of relapse in multiple sclerosis
Author(s): Giannetti P | Niccolini F | Nicholas R
Volume: 2012
Issue: default
Year: 2012
Author(s): Giannetti P | Niccolini F | Nicholas R Volume: 2012 Issue: default Year: 2012
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy
Author(s): Buxbaum JN
Volume: 2012
Issue: default
Year: 2012
Author(s): Buxbaum JN Volume: 2012 Issue: default Year: 2012
Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safety
Author(s): Pouratian N | Thakkar S | Kim W | Bronstein JM
Volume: 2012
Issue: default
Year: 2012
Author(s): Pouratian N | Thakkar S | Kim W | Bronstein JM Volume: 2012 Issue: default Year: 2012
Optimal management for people with severe spasticity
Author(s): Shilt JS | Seibert PS | Kadyan V
Volume: 2012
Issue: default
Year: 2012
Author(s): Shilt JS | Seibert PS | Kadyan V Volume: 2012 Issue: default Year: 2012
Amyotrophic lateral sclerosis: update and new developments
Author(s): Pratt AJ | Getzoff ED | Perry JJ
Volume: 2012
Issue: default
Year: 2012
Author(s): Pratt AJ | Getzoff ED | Perry JJ Volume: 2012 Issue: default Year: 2012
Walking impairment in patients with multiple sclerosis – a new therapeutic approach and clinical potential of dalfampridine extended release tablets
Author(s): Henney III HR | Blight AR
Volume: 2012
Issue: default
Year: 2012
Author(s): Henney III HR | Blight AR Volume: 2012 Issue: default Year: 2012
Emerging treatment options for spasticity in multiple sclerosis – clinical utility of cannabinoids
Author(s): Ashton JC
Volume: 2011
Issue: default
Year: 2011
Author(s): Ashton JC Volume: 2011 Issue: default Year: 2011
Profile of oral laquinimod and its potential in the treatment of multiple sclerosis
Author(s): West MS | Miravalle A
Volume: 2011
Issue: default
Year: 2011
Author(s): West MS | Miravalle A Volume: 2011 Issue: default Year: 2011
Therapeutic application of monoclonal antibodies in multiple sclerosis: focus on alemtuzumab
Author(s): Niino M
Volume: 2011
Issue: default
Year: 2011
Author(s): Niino M Volume: 2011 Issue: default Year: 2011
Critical appraisal and role of memantine extended-release in the management of Alzheimer’s disease
Author(s): Singh I | Grossberg GT
Volume: 2011
Issue: default
Year: 2011
Author(s): Singh I | Grossberg GT Volume: 2011 Issue: default Year: 2011
Evaluation of glycopyrrolate in the treatment of chronic drooling
Author(s): Reddihough DS | Reid SM | Plover C
Volume: 2011
Issue: default
Year: 2011
Author(s): Reddihough DS | Reid SM | Plover C Volume: 2011 Issue: default Year: 2011
